Clinical Trial Update: Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients [NA]

View source ↗

Summary

This completed clinical trial evaluated whether giving a GnRH analogue during chemotherapy can prevent ovarian function damage in Hodgkin lymphoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• GnRH analogue (Gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Masaryk University | Conditions: Hodgkin Lymphoma, Hodgkin Disease | NA | Status: COMPLETED